Otc - Active Ingredient
Phenolphthalein, Senna, Sulphur
Laxease
FDA Label NDC 69825-006
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Adven Biotech Private Limited for the product Laxease (NDC 69825-006). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, dosage & administration, warnings, otc - purpose, indications & usage, inactive ingredient, otc - do not use, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Dosage & Administration
Adults: Take 3 tablets at bed time.
Children under 18 years: Take 1 tablets at bed time or as prescribed by the physician.
Warnings
If symptons persist or worsen, a physician should be consulted. Keep out of reach of children. Do not use, if known sentivity to any of its ingredients exists. Replace cap tightly. If pregnant or breast feeding, ask a health care professional before use.
Otc - Purpose
Eases hard and irregular stool. Helps in case of piles.
Indications & Usage
Eases bowel movement.
Inactive Ingredient
Sugar of milk
Otc - Do Not Use
Do not use if neck wrap or foil inner seal is broken or missing. Protect from moisture, direct sunlight and heat.
Package Label.Principal Display Panel
Laxease Tablets Label (Laxesetablets)
* Please review the disclaimer below.
